HFE-associated hereditary Hemochromatosis (HFE-HH) is the most frequent monogenic genetic disorder in the Caucasian population. The excessive iron storage in organs are common, affecting the liver mostly (> 90 %) resulting in a potentially severe liver damage (fibrosis, cirrhosis). In recent years, hepatic and cardiac iron deposition has been studied in detail. Due to its involvement in the development of diabetes - a frequent co-morbidity in iron overload diseases - pancreatic iron should become a field of interest. This study aims to determine the pancreatic iron and fat content in patients with HFE-HH.